Wenjie Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wenjie Peng has a total of 222 co-authors. Here are the top co-authors by number of shared publications:
Ryan McBride
14 shared publications- James C. Paulson
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
11 shared publications - Robert Paul de Vries
Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands
9 shared publications James C. Paulson
8 shared publications- Andrew J. Thompson
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
6 shared publications - Biao Yu
Chinese Academy of Sciences No. 345 Lingling Road
5 shared publications
Latest Publications
- 30 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (31) , 23084-23095
Programmable One-Tube Sialic Acid Derivatization Enables Dual-Mode N -Glycomics of Low-Input Samples
Low-input glycomics remains particularly challenging for sialylated N-glycans because rigorous linkage-specific derivatization often increases sample handling, disperses signal across multiple linkage isomers, and compromises sensitivity. Here, we report a programmable one-tube workflow that integrates cell lysis, N-glycan release, sialic acid derivatization, and purification in a single microcentrifuge tube for highly sensitive N-glycome profiling. By controlling ammonia activity and reaction time after ethyl esterification, the workflow enables optional sialic acid linkage-specific, linkage-nonspecific, and sequential dual-mode analyses on the same low-input sample. On a standard mass spectrometry platform, the method demonstrated direct N-glycomic profiling from nanogram-scale glycoprotein inputs, nanoliter-scale human serum, and only a few thousand primary T cells. Applied to splenic B cells from an LPS-induced inflammatory model, a marked remodeling of the N-glycome from high-mannose species toward sialylated complex glycans was revealed, while maintaining an unchanged α2,3/α2,6 overall ratio. These results establish a chemistry-programmable route to dual-mode N-glycomics for low-input samples and expand the practical scope of linkage-resolved glycomic analysis in mass-limited biospecimens.
- 30 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (31) , 23084-23095
Programmable One-Tube Sialic Acid Derivatization Enables Dual-Mode N -Glycomics of Low-Input Samples
Low-input glycomics remains particularly challenging for sialylated N-glycans because rigorous linkage-specific derivatization often increases sample handling, disperses signal across multiple linkage isomers, and compromises sensitivity. Here, we report a programmable one-tube workflow that integrates cell lysis, N-glycan release, sialic acid derivatization, and purification in a single microcentrifuge tube for highly sensitive N-glycome profiling. By controlling ammonia activity and reaction time after ethyl esterification, the workflow enables optional sialic acid linkage-specific, linkage-nonspecific, and sequential dual-mode analyses on the same low-input sample. On a standard mass spectrometry platform, the method demonstrated direct N-glycomic profiling from nanogram-scale glycoprotein inputs, nanoliter-scale human serum, and only a few thousand primary T cells. Applied to splenic B cells from an LPS-induced inflammatory model, a marked remodeling of the N-glycome from high-mannose species toward sialylated complex glycans was revealed, while maintaining an unchanged α2,3/α2,6 overall ratio. These results establish a chemistry-programmable route to dual-mode N-glycomics for low-input samples and expand the practical scope of linkage-resolved glycomic analysis in mass-limited biospecimens.
- Open Access
- 2 March 2026
- Published by Wiley in Advanced Science
- Vol. 13 (26) , e22474
One‐Step Glycoengineering of NK Cells With High‐Affinity Siglec Ligands for Cancer Immunotherapy
Siglecs, a family of sialic acid (Sia)‐binding immunomodulatory receptors selectively expressed on immune cells, are promising immunotherapeutic targets. While synthetic Sia derivatives can manipulate the Sia‐Siglec axis with high affinity, their therapeutic application has been hampered by the poor substrate tolerance of wild‐type CMP‐sialic acid synthase (CSS) for sterically demanding analogs. Here, we report a structure‐guided engineering strategy to evolve Neisseria meningitidis CMP‐Sia synthetase (NmCSS) for enhanced activity with bulky substrates. Coupling this optimized NmCSS variant with a sialyltransferase enabled a scalable “one‐pot two‐enzyme” (OPTE) synthesis of diverse sialoside analogs. Screening this library on glycan microarrays revealed novel high‐affinity ligands with selective Siglec binding profiles. Leveraging the OPTE system, we achieved single‐step glycoengineering of natural killer (NK)‐92MI cells with tailored Siglec‐2 or Siglec‐3 ligands, which exhibited potent cytotoxicity against B‐cell lymphoma (Siglec‐2 + ) and acute myeloid leukemia (Siglec‐3 + ) models. These engineered NK cells displayed significantly enhanced tumor killing capacity, mediated by enhanced granzyme release and cytokine production while maintaining excellent cell viability. This modular platform addresses critical limitations in enzymatic synthesis of modified sialosides and their efficient display on therapeutic cells. Our work establishes a versatile and practical platform for developing next‐generation immunotherapies that precisely target the Sia‐Siglec axis with improved specificity and functionality.
- 2 March 2026
- Published by Wiley in Advanced Science
- Vol. 13 (26) , e22474
Open AccessOne‐Step Glycoengineering of NK Cells With High‐Affinity Siglec Ligands for Cancer Immunotherapy
Siglecs, a family of sialic acid (Sia)‐binding immunomodulatory receptors selectively expressed on immune cells, are promising immunotherapeutic targets. While synthetic Sia derivatives can manipulate the Sia‐Siglec axis with high affinity, their therapeutic application has been hampered by the poor substrate tolerance of wild‐type CMP‐sialic acid synthase (CSS) for sterically demanding analogs. Here, we report a structure‐guided engineering strategy to evolve Neisseria meningitidis CMP‐Sia synthetase (NmCSS) for enhanced activity with bulky substrates. Coupling this optimized NmCSS variant with a sialyltransferase enabled a scalable “one‐pot two‐enzyme” (OPTE) synthesis of diverse sialoside analogs. Screening this library on glycan microarrays revealed novel high‐affinity ligands with selective Siglec binding profiles. Leveraging the OPTE system, we achieved single‐step glycoengineering of natural killer (NK)‐92MI cells with tailored Siglec‐2 or Siglec‐3 ligands, which exhibited potent cytotoxicity against B‐cell lymphoma (Siglec‐2 + ) and acute myeloid leukemia (Siglec‐3 + ) models. These engineered NK cells displayed significantly enhanced tumor killing capacity, mediated by enhanced granzyme release and cytokine production while maintaining excellent cell viability. This modular platform addresses critical limitations in enzymatic synthesis of modified sialosides and their efficient display on therapeutic cells. Our work establishes a versatile and practical platform for developing next‐generation immunotherapies that precisely target the Sia‐Siglec axis with improved specificity and functionality.
- 9 April 2024
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 26 (17) , 13441-13451
A kinetic model reveals the critical gating motifs for donor-substrate loading into Actinobacillus pleuropneumoniae N-glycosyltransferase
Through constructing a kinetic model based on extensive all-atom molecular dynamics simulations, the key structural motifs in ApNGTQ469A responsible for mediating the donor-substrate loading are pinpointed.
- 9 April 2024
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 26 (17) , 13441-13451
A kinetic model reveals the critical gating motifs for donor-substrate loading into Actinobacillus pleuropneumoniae N-glycosyltransferase
Through constructing a kinetic model based on extensive all-atom molecular dynamics simulations, the key structural motifs in ApNGTQ469A responsible for mediating the donor-substrate loading are pinpointed.
- Open Access
- 7 August 2023
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 3 (8) , 2144-2155
Investigation of the Catalytic Mechanism of a Soluble N-glycosyltransferase Allows Synthesis of N-glycans at Noncanonical Sequons
The soluble N-glycosyltransferase from Actinobacilluspleuropneumoniae (ApNGT) can establish an N-glycosidic bondat the asparagine residuein the Asn-Xaa-Ser/Thr consensus sequon and is one of the most promisingtools for N-glycoprotein production. Here, by integrating computationaland experimental strategies, we revealed the molecular mechanism ofthe substrate recognition and following catalysis of ApNGT. Thesefindings allowed us to pinpoint a key structural motif ((DVYM218)-D-215) in ApNGT responsible for the peptide substraterecognition. Moreover, Y222 and H371 of ApNGT were found to participatein activating the acceptor Asn. The constructed models were supportedby further crystallographic studies and the functional roles of theidentified residues were validated by measuring the glycosylationactivity of various mutants against a library of synthetic peptides.Intriguingly, with particular mutants, site-selective N-glycosylationof canonical or noncanonical sequons within natural polypeptides fromthe SARS-CoV-2 spike protein could be achieved, which were used toinvestigate the biological roles of the N-glycosylation in membranefusion during virus entry. Our study thus provides in-depth molecularmechanisms underlying the substrate recognition and catalysis forApNGT, leading to the synthesis of previously unknown chemically definedN-glycoproteins for exploring the biological importance of the N-glycosylationat a specific site.
- 7 August 2023
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 3 (8) , 2144-2155
Open AccessInvestigation of the Catalytic Mechanism of a Soluble N-glycosyltransferase Allows Synthesis of N-glycans at Noncanonical Sequons
The soluble N-glycosyltransferase from Actinobacilluspleuropneumoniae (ApNGT) can establish an N-glycosidic bondat the asparagine residuein the Asn-Xaa-Ser/Thr consensus sequon and is one of the most promisingtools for N-glycoprotein production. Here, by integrating computationaland experimental strategies, we revealed the molecular mechanism ofthe substrate recognition and following catalysis of ApNGT. Thesefindings allowed us to pinpoint a key structural motif ((DVYM218)-D-215) in ApNGT responsible for the peptide substraterecognition. Moreover, Y222 and H371 of ApNGT were found to participatein activating the acceptor Asn. The constructed models were supportedby further crystallographic studies and the functional roles of theidentified residues were validated by measuring the glycosylationactivity of various mutants against a library of synthetic peptides.Intriguingly, with particular mutants, site-selective N-glycosylationof canonical or noncanonical sequons within natural polypeptides fromthe SARS-CoV-2 spike protein could be achieved, which were used toinvestigate the biological roles of the N-glycosylation in membranefusion during virus entry. Our study thus provides in-depth molecularmechanisms underlying the substrate recognition and catalysis forApNGT, leading to the synthesis of previously unknown chemically definedN-glycoproteins for exploring the biological importance of the N-glycosylationat a specific site.
- Open Access
- 3 May 2023
- Published by China Anti-cancer Association in Cancer Biology & Medicine
- Vol. 20 (5) , 1-16
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
Malignant tumors are complex structures composed of cancer cells and tumor microenvironmental cells. In this complex structure, cells cross-talk and interact, thus jointly promoting cancer development and metastasis. Recently, immunoregulatory molecule-based cancer immunotherapy has greatly improved treatment efficacy for solid cancers, thus enabling some patients to achieve persistent responses or cure. However, owing to the development of drug-resistance and the low response rate, immunotherapy against the available targets PD-1/PD-L1 or CTLA-4 has limited benefits. Although combination therapies have been proposed to enhance the response rate, severe adverse effects are observed. Thus, alternative immune checkpoints must be identified. The SIGLECs are a family of immunoregulatory receptors (known as glyco-immune checkpoints) discovered in recent years. This review systematically describes the molecular characteristics of the SIGLECs, and discusses recent progress in areas including synthetic ligands, monoclonal antibody inhibitors, and Chimeric antigen receptor T (CAR-T) cells, with a focus on available strategies for blocking the sialylated glycan-SIGLEC axis. Targeting glyco-immune checkpoints can expand the scope of immune checkpoints and provide multiple options for new drug development.
- 3 May 2023
- Published by China Anti-cancer Association in Cancer Biology & Medicine
- Vol. 20 (5) , 1-16
Open AccessRecent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
Malignant tumors are complex structures composed of cancer cells and tumor microenvironmental cells. In this complex structure, cells cross-talk and interact, thus jointly promoting cancer development and metastasis. Recently, immunoregulatory molecule-based cancer immunotherapy has greatly improved treatment efficacy for solid cancers, thus enabling some patients to achieve persistent responses or cure. However, owing to the development of drug-resistance and the low response rate, immunotherapy against the available targets PD-1/PD-L1 or CTLA-4 has limited benefits. Although combination therapies have been proposed to enhance the response rate, severe adverse effects are observed. Thus, alternative immune checkpoints must be identified. The SIGLECs are a family of immunoregulatory receptors (known as glyco-immune checkpoints) discovered in recent years. This review systematically describes the molecular characteristics of the SIGLECs, and discusses recent progress in areas including synthetic ligands, monoclonal antibody inhibitors, and Chimeric antigen receptor T (CAR-T) cells, with a focus on available strategies for blocking the sialylated glycan-SIGLEC axis. Targeting glyco-immune checkpoints can expand the scope of immune checkpoints and provide multiple options for new drug development.
- 10 August 2022
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (15) , e0095822
The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint
Spike N-terminal domains (S-NTD) of sarbecoviruses are highly diverse; however, their function remains largely understudied compared with the receptor-binding domains (RBD). Here, we show that sarbecovirus S-NTD can be phylogenetically clustered into five clades and exhibit various levels of glycan binding in vitro .
- 10 August 2022
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (15) , e0095822
The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint
Spike N-terminal domains (S-NTD) of sarbecoviruses are highly diverse; however, their function remains largely understudied compared with the receptor-binding domains (RBD). Here, we show that sarbecovirus S-NTD can be phylogenetically clustered into five clades and exhibit various levels of glycan binding in vitro .
- Open Access
- 17 October 2018
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 57 (46) , 15051-15055
Avenues to Characterize the Interactions of Extended N‐Glycans with Proteins by NMR Spectroscopy: The Influenza Hemagglutinin Case
Long‐chain multiantenna N‐glycans are extremely complex molecules. Their inherent flexibility and the presence of repetitions of monosaccharide units in similar chemical environments hamper their full characterization by X‐ray diffraction or standard NMR methods. Herein, the successful conformational and interaction analysis of a sialylated tetradecasaccharide N‐glycan presenting two LacNAc repetitions at each arm is presented. This glycan has been identified as the receptor of the hemagglutinin protein of pathogenic influenza viruses. To accomplish this study, a N‐glycan conjugated with a lanthanide binding tag has been synthesized, enabling analysis of the system by paramagnetic NMR. Under paramagnetic conditions, the NMR signals of each sugar unit in the glycan have been determined. Furthermore, a detailed binding epitope of the tetradecasaccharide N‐glycan in the presence of HK/68 hemagglutinin is described.
- 17 October 2018
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 57 (46) , 15051-15055
Open AccessAvenues to Characterize the Interactions of Extended N‐Glycans with Proteins by NMR Spectroscopy: The Influenza Hemagglutinin Case
Long‐chain multiantenna N‐glycans are extremely complex molecules. Their inherent flexibility and the presence of repetitions of monosaccharide units in similar chemical environments hamper their full characterization by X‐ray diffraction or standard NMR methods. Herein, the successful conformational and interaction analysis of a sialylated tetradecasaccharide N‐glycan presenting two LacNAc repetitions at each arm is presented. This glycan has been identified as the receptor of the hemagglutinin protein of pathogenic influenza viruses. To accomplish this study, a N‐glycan conjugated with a lanthanide binding tag has been synthesized, enabling analysis of the system by paramagnetic NMR. Under paramagnetic conditions, the NMR signals of each sugar unit in the glycan have been determined. Furthermore, a detailed binding epitope of the tetradecasaccharide N‐glycan in the presence of HK/68 hemagglutinin is described.
- Open Access
- 1 July 2018
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 24 (7) , 1128-1238
Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004–2010
Influenza viruses exist in each host as a collection of genetically diverse variants, which might enhance their adaptive potential. To assess the genetic and functional diversity of highly pathogenic avian influenza A(H5N1) viruses within infected humans, we used deep-sequencing methods to characterize samples obtained from infected patients in northern Vietnam during 2004–2010 on different days after infection, from different anatomic sites, or both. We detected changes in virus genes that affected receptor binding, polymerase activity, or interferon antagonism, suggesting that these factors could play roles in influenza virus adaptation to humans. However, the frequency of most of these mutations remained low in the samples tested, implying that they were not efficiently selected within these hosts. Our data suggest that adaptation of influenza A(H5N1) viruses is probably stepwise and depends on accumulating combinations of mutations that alter function while maintaining fitness.
- 1 July 2018
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 24 (7) , 1128-1238
Open AccessDiversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004–2010
Influenza viruses exist in each host as a collection of genetically diverse variants, which might enhance their adaptive potential. To assess the genetic and functional diversity of highly pathogenic avian influenza A(H5N1) viruses within infected humans, we used deep-sequencing methods to characterize samples obtained from infected patients in northern Vietnam during 2004–2010 on different days after infection, from different anatomic sites, or both. We detected changes in virus genes that affected receptor binding, polymerase activity, or interferon antagonism, suggesting that these factors could play roles in influenza virus adaptation to humans. However, the frequency of most of these mutations remained low in the samples tested, implying that they were not efficiently selected within these hosts. Our data suggest that adaptation of influenza A(H5N1) viruses is probably stepwise and depends on accumulating combinations of mutations that alter function while maintaining fitness.
- 15 May 2018
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (10)
Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation
All human influenza pandemics have originated from avian influenza viruses. Although multiple changes are needed for an avian virus to be able to transmit between humans, binding to human-type receptors is essential. Several research groups have reported mutations in H5N1 viruses that exhibit specificity for human-type receptors and promote respiratory droplet transmission between ferrets. Upon detailed analysis, we have found that these mutants exhibit significant differences in fine receptor specificity compared to human H1N1 and H3N2 and retain avian-type receptor binding. We have recently shown that human influenza viruses preferentially bind to α2-6-sialylated branched N-linked glycans, where the sialic acids on each branch can bind to receptor sites on two protomers of the same hemagglutinin (HA) trimer. In this binding mode, the glycan projects over the 190 helix at the top of the receptor-binding pocket, which in H5N1 would create a stearic clash with lysine at position 193. Thus, we hypothesized that a K193T mutation would improve binding to branched N-linked receptors. Indeed, the addition of the K193T mutation to the H5 HA of a respiratory-droplet-transmissible virus dramatically improves both binding to human trachea epithelial cells and specificity for extended α2-6-sialylated N-linked glycans recognized by human influenza viruses. IMPORTANCE Infections by avian H5N1 viruses are associated with a high mortality rate in several species, including humans. Fortunately, H5N1 viruses do not transmit between humans because they do not bind to human-type receptors. In 2012, three seminal papers have shown how these viruses can be engineered to transmit between ferrets, the human model for influenza virus infection. Receptor binding, among others, was changed, and the viruses now bind to human-type receptors. Receptor specificity was still markedly different compared to that of human influenza viruses. Here we report an additional mutation in ferret-transmissible H5N1 that increases human-type receptor binding. K193T seems to be a common receptor specificity determinant, as it increases human-type receptor binding in multiple subtypes. The K193T mutation can now be used as a marker during surveillance of emerging viruses to assess potential pandemic risk.
- 15 May 2018
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (10)
Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation
All human influenza pandemics have originated from avian influenza viruses. Although multiple changes are needed for an avian virus to be able to transmit between humans, binding to human-type receptors is essential. Several research groups have reported mutations in H5N1 viruses that exhibit specificity for human-type receptors and promote respiratory droplet transmission between ferrets. Upon detailed analysis, we have found that these mutants exhibit significant differences in fine receptor specificity compared to human H1N1 and H3N2 and retain avian-type receptor binding. We have recently shown that human influenza viruses preferentially bind to α2-6-sialylated branched N-linked glycans, where the sialic acids on each branch can bind to receptor sites on two protomers of the same hemagglutinin (HA) trimer. In this binding mode, the glycan projects over the 190 helix at the top of the receptor-binding pocket, which in H5N1 would create a stearic clash with lysine at position 193. Thus, we hypothesized that a K193T mutation would improve binding to branched N-linked receptors. Indeed, the addition of the K193T mutation to the H5 HA of a respiratory-droplet-transmissible virus dramatically improves both binding to human trachea epithelial cells and specificity for extended α2-6-sialylated N-linked glycans recognized by human influenza viruses. IMPORTANCE Infections by avian H5N1 viruses are associated with a high mortality rate in several species, including humans. Fortunately, H5N1 viruses do not transmit between humans because they do not bind to human-type receptors. In 2012, three seminal papers have shown how these viruses can be engineered to transmit between ferrets, the human model for influenza virus infection. Receptor binding, among others, was changed, and the viruses now bind to human-type receptors. Receptor specificity was still markedly different compared to that of human influenza viruses. Here we report an additional mutation in ferret-transmissible H5N1 that increases human-type receptor binding. K193T seems to be a common receptor specificity determinant, as it increases human-type receptor binding in multiple subtypes. The K193T mutation can now be used as a marker during surveillance of emerging viruses to assess potential pandemic risk.
- Top Cited PapersOpen Access
- 18 September 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (40) , E8508-E8517
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
Middle East respiratory syndrome coronavirus (MERS-CoV) targets the epithelial cells of the respiratory tract both in humans and in its natural host, the dromedary camel. Virion attachment to host cells is mediated by 20-nm-long homotrimers of spike envelope protein S. The N-terminal subunit of each S protomer, called S1, folds into four distinct domains designated S1A through S1D. Binding of MERS-CoV to the cell surface entry receptor dipeptidyl peptidase 4 (DPP4) occurs via S1B. We now demonstrate that in addition to DPP4, MERS-CoV binds to sialic acid (Sia). Initially demonstrated by hemagglutination assay with human erythrocytes and intact virus, MERS-CoV Sia-binding activity was assigned to S subdomain S1A. When multivalently displayed on nanoparticles, S1 or S1A bound to human erythrocytes and to human mucin in a strictly Sia-dependent fashion. Glycan array analysis revealed a preference for α2,3-linked Sias over α2,6-linked Sias, which correlates with the differential distribution of α2,3-linked Sias and the predominant sites of MERS-CoV replication in the upper and lower respiratory tracts of camels and humans, respectively. Binding is hampered by Sia modifications such as 5-N-glycolylation and (7,)9-O-acetylation. Depletion of cell surface Sia by neuraminidase treatment inhibited MERS-CoV entry of Calu-3 human airway cells, thus providing direct evidence that virus–Sia interactions may aid in virion attachment. The combined observations lead us to propose that high-specificity, low-affinity attachment of MERS-CoV to sialoglycans during the preattachment or early attachment phase may form another determinant governing the host range and tissue tropism of this zoonotic pathogen.
- 18 September 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (40) , E8508-E8517
Top Cited PapersOpen AccessIdentification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
Middle East respiratory syndrome coronavirus (MERS-CoV) targets the epithelial cells of the respiratory tract both in humans and in its natural host, the dromedary camel. Virion attachment to host cells is mediated by 20-nm-long homotrimers of spike envelope protein S. The N-terminal subunit of each S protomer, called S1, folds into four distinct domains designated S1A through S1D. Binding of MERS-CoV to the cell surface entry receptor dipeptidyl peptidase 4 (DPP4) occurs via S1B. We now demonstrate that in addition to DPP4, MERS-CoV binds to sialic acid (Sia). Initially demonstrated by hemagglutination assay with human erythrocytes and intact virus, MERS-CoV Sia-binding activity was assigned to S subdomain S1A. When multivalently displayed on nanoparticles, S1 or S1A bound to human erythrocytes and to human mucin in a strictly Sia-dependent fashion. Glycan array analysis revealed a preference for α2,3-linked Sias over α2,6-linked Sias, which correlates with the differential distribution of α2,3-linked Sias and the predominant sites of MERS-CoV replication in the upper and lower respiratory tracts of camels and humans, respectively. Binding is hampered by Sia modifications such as 5-N-glycolylation and (7,)9-O-acetylation. Depletion of cell surface Sia by neuraminidase treatment inhibited MERS-CoV entry of Calu-3 human airway cells, thus providing direct evidence that virus–Sia interactions may aid in virion attachment. The combined observations lead us to propose that high-specificity, low-affinity attachment of MERS-CoV to sialoglycans during the preattachment or early attachment phase may form another determinant governing the host range and tissue tropism of this zoonotic pathogen.